[HTML][HTML] Immunological aspects of approved MS therapeutics
Multiple sclerosis (MS) is the most common neurological immune-mediated disease leading
to disability in young adults. The outcome of the disease is unpredictable, and over time …
to disability in young adults. The outcome of the disease is unpredictable, and over time …
Immunological Aspects of Approved MS Therapeutics
PS Rommer, R Milo, MH Han, S Satyanarayan… - Front …, 2019 - kups.ub.uni-koeln.de
Multiple sclerosis (MS) is the most common neurological immune-mediated disease leading
to disability in young adults. The outcome of the disease is unpredictable, and over time …
to disability in young adults. The outcome of the disease is unpredictable, and over time …
[引用][C] Immunological Aspects of Approved MS Therapeutics
PS Rommer, R Milo, MH Han, S Satyanarayan… - Frontiers in …, 2019 - cir.nii.ac.jp
Immunological aspects of approved MS therapeutics
PS Rommer, R Milo, MH Han… - Frontiers in …, 2019 - utsouthwestern.elsevierpure.com
Multiple sclerosis (MS) is the most common neurological immune-mediated disease leading
to disability in young adults. The outcome of the disease is unpredictable, and over time …
to disability in young adults. The outcome of the disease is unpredictable, and over time …
Immunological aspects of approved MS therapeutics
PS Rommer, R Milo, MH Han… - Frontiers in …, 2019 - ohiostate.elsevierpure.com
Multiple sclerosis (MS) is the most common neurological immune-mediated disease leading
to disability in young adults. The outcome of the disease is unpredictable, and over time …
to disability in young adults. The outcome of the disease is unpredictable, and over time …
[引用][C] Immunological Aspects of Approved MS Therapeutics.
PS Rommer, R Milo, MH Han… - FRONTIERS IN …, 2019 - pure.pmu.ac.at
Immunological Aspects of Approved MS Therapeutics. — PMU Forschungsportal Zur
Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln PMU …
Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln PMU …
Immunological Aspects of Approved MS Therapeutics
PS Rommer, R Milo, MH Han… - Frontiers in …, 2019 - portal.findresearcher.sdu.dk
Multiple sclerosis (MS) is the most common neurological immune-mediated disease leading
to disability in young adults. The outcome of the disease is unpredictable, and over time …
to disability in young adults. The outcome of the disease is unpredictable, and over time …
Immunological Aspects of Approved MS Therapeutics
PS Rommer, R Milo, MH Han… - … –From Bench to …, 2020 - books.google.com
Multiple sclerosis (MS) is the most common neurological immune-mediated disease leading
to disability in young adults. The outcome of the disease is unpredictable, and overtime …
to disability in young adults. The outcome of the disease is unpredictable, and overtime …
Immunological Aspects of Approved MS Therapeutics.
PS Rommer, R Milo, MH Han… - Frontiers in …, 2019 - europepmc.org
Multiple sclerosis (MS) is the most common neurological immune-mediated disease leading
to disability in young adults. The outcome of the disease is unpredictable, and over time …
to disability in young adults. The outcome of the disease is unpredictable, and over time …
Immunological aspects of approved MS therapeutics
PS Rommer, R Milo, MH Han… - Frontiers in …, 2019 - weizmann.elsevierpure.com
Multiple sclerosis (MS) is the most common neurological immune-mediated disease leading
to disability in young adults. The outcome of the disease is unpredictable, and over time …
to disability in young adults. The outcome of the disease is unpredictable, and over time …